Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC

Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC

EGFR-TKI is widely used for EGFR-mutant NSCLC patients. Bleeding is reported as a neglected adverse effect induced by EGFR-TKI. Female patients with lung adenocarcinoma have a high frequency of EGFR mutations. This study investigated the effect of EGFR-TKI on the menstrual cycle, especially on bleed...

Full description

Bibliographic Details
Main Authors: Min Yu, Xiaoyu Li, Xueqian Wu, Weiya Wang, Yanying Li, Yan Zhang, Shuang Zhang, Yongsheng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
vaginal bleeding
non-small cell lung cancer
EGFR tyrosine kinase inhibitor
epidermal growth factor receptor
premenopausal female
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.805538/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.805538/full

Similar Items